Physicians Guide For Diagnosing Dementia With Lewy Bodies PDF Download

Connecting minds with knowledge. With its acclaimed authors, cutting-edge content, emphasis on medical relevance, and coverage based on landmark research, this book has earned an impeccable reputation as an authoritative and exciting curated research journal and learning aid, perfect for students, medical professionals and other sophisticated readers. Hundreds of hours were spent compiling and editing this volume such that its readers are conveniently brought up-to-speed on the subject, presenting many of the latest and most important developments in the field. This volume presents 25 cutting-edge research papers on Alzheimer's, curated by our experts for maximal significance. Articles include: Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis; Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-Mediated Neurodegeneration; Microglia receptors and their implications in the response to amyloid beta for Alzheimer's disease pathogenesis; Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease; Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy; Vascular risk factors and Alzheimer's disease; Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review; Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease; A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer's disease; Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model; Amyloid Beta and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation; Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease; Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study; First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model; A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles; Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease; and many more.